Search results
Should You Buy This Stock After a Regulatory Setback?
Motley Fool via Yahoo Finance· 5 days agoThe vaccine maker's shares are down by 43% since then. Moderna isn't resting on its...ran into a...
Peninsula cancer test maker lands key nod from FDA panel, a step toward a big payday - San Francisco...
The Business Journals· 7 days agoShares of Guardant Health Inc. closed Friday more than 13% higher day-over-day, after the Palo Alto...
Baby formula maker recalls batch after failing to register formula with FDA - ABC Columbia
ABC Columbia· 2 days agoDairy Manufacturers, Inc. is recalling infant formula sold under the names Crecelac and Farmalac.
Bottom Line: George Washington University lobbied up amid campus protest pressure
The Hill via Yahoo News· 1 day agoHigher education Amid scrutiny of its handling of pro-Palestinian protests on campus earlier this...
Clorox and these other stocks are on the verge of marking a death cross chart pattern
CNBC· 1 day agoA small group of stocks is on the verge of forming a worrisome chart pattern known as a "death cross...
New study points to possible link between tattoos and lymphoma, but experts say much more research...
KTBS Shreveport· 1 day agoThe researchers, from Lund University, said they wanted to do the study because so little is known...
10 AI applications for companies that want to streamline their business and improve customer...
Business Insider via Yahoo News· 20 hours agoComplying with regulations Tetra Pak uses AI to create cheese recipes that meet Food and Drug ...
3 Biotech Stocks That Could Be Millionaire-Makers: May Edition
InvestorPlace· 6 days agoAs we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused...
American sunscreen options are limited compared to other countries. Here's why.
CBS News· 3 days agoThe 1938 U.S. law classifies sunscreen as a drug and requires animal testing rather than as a...
Ozempic cuts risk of chronic kidney disease complications, study finds
Minneapolis-St. Paul Star Tribune· 7 days agoSemaglutide, the compound in the blockbuster drugs Ozempic and Wegovy, dramatically reduced the risk...